(Q33828348)

29 July 2017

title

Ab-externo AAV-mediated gene delivery to the suprachoroidal space using a 250 micron flexible microcatheter (English)

1 reference

29 July 2017

Marc C Peden

1

1 reference

29 July 2017

Jeff Min

2

1 reference

29 July 2017

Craig Meyers

3

1 reference

29 July 2017

Zachary Lukowski

4

1 reference

29 July 2017

Qiuhong Li

5

1 reference

29 July 2017

Sanford L Boye

6

1 reference

29 July 2017

Monica Levine

7

1 reference

29 July 2017

William W Hauswirth

8

1 reference

29 July 2017

Ramakrishna Ratnakaram

9

1 reference

29 July 2017

William Dawson

10

1 reference

29 July 2017

Wesley C Smith

11

1 reference

29 July 2017

Mark B Sherwood

12

1 reference

29 July 2017

language of work or name

English

0 references

publication date

11 February 2011

1 reference

29 July 2017

1 reference

29 July 2017

volume

6

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

e17140

1 reference

Creative Commons Attribution 4.0 International

29 July 2017

copyright license

start time

11 February 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037961

Gene therapy for red-green colour blindness in adult primates

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037961

Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037961

Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037961

Safety and efficacy of gene transfer for Leber's congenital amaurosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037961

Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037961

Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037961

AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3037961

Effect of gene therapy on visual function in Leber's congenital amaurosis

28 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0017140

Canaloplasty: circumferential viscodilation and tensioning of Schlemm's canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: interim clinical study analysis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0017140

Comparative analysis of in vivo and in vitro AAV vector transduction in the neonatal mouse retina: effects of serotype and site of administration.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0017140

10.1371/JOURNAL.PONE.0017140

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

0 references

1 reference

29 July 2017

1 reference